Co-Diagnostics Acquires At-Home, Point-of-Care COVID Platform
The company expects that the acquisition will streamline the commercialization of the Eikon platform and YourTest PCR device as it nears completion.
Read MorePosted by Andy Lundin | Dec 23, 2021 | Company News, POC Reagents & Test Kits |
The company expects that the acquisition will streamline the commercialization of the Eikon platform and YourTest PCR device as it nears completion.
Read MorePosted by Chris Wolski | Dec 9, 2021 | Diagnostic Technologies |
Industry experts predict a year of change and transformation ahead as the COVID-19 pandemic continues to influence the way clinical labs operate.
Read MorePosted by Andy Lundin | Dec 9, 2021 | Covid 19, Immunoassay Reagents & test Kits |
A new SARS-CoV-2 rapid antigen test is able to produces results in minutes, without the need for additional equipment or specially-trained personnel.
Read MorePosted by Andy Lundin | Dec 6, 2021 | Histology, Microbiology, Molecular Diagnostics |
In a demonstration, the technique distinguished between healthy samples and either cancerous or pre-cancerous cells with nearly 100 percent accuracy.
Read MorePosted by Andy Lundin | Dec 2, 2021 | Sexually Transmitted Diseases, Swabs, Womens Health |
The STI panel may also reduce time to results, rates of over- and under-treatment, and hands-on-time required to run the Visby test by clinic staff.
Read More